Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction
Weinstock, B.S.
Journal of Invasive Cardiology 14(2) 100-104; Quiz: 104-105
2002
ISSN/ISBN: 1042-3931 PMID: 11818648 Document Number: 550041
Document emailed within 1 workday
Related Documents
Gum, P.A.; Lincoff, A.M. 2003: Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction International Journal of Clinical Practice 57(1): 43-48Koziński, M.; Kasprzak, Mł.; Rychter, M.; Navarese, E.Pio.; Sukiennik, A.; Kubica, J. 2012: Primary percutaneous coronary intervention facilitated with supersaturated oxygen therapy in a patient with anterior myocardial infarction: a case report and literature review Kardiologia Polska 70(2): 172-174
Kereiakes, D.J.; Fry, E.; Matthai, W.; Niederman, A.; Barr, L.; Brodie, B.; Zidar, J.; Casale, P.; Christy, G.; Moliterno, D.; Lengerich, R.; Broderick, T.; Shimshak, T.; Cohen, M. 2000: Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first" Journal of Invasive Cardiology 12 Suppl A: 1a-5a
Siudak, Z.; Rakowski, T.; Dziewierz, A.; Janzon, M.; Birkemeyer, R.; Stefaniak, J.; Partyka, Łu.; Zmudka, K.; Dudek, D. 2010: Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry Kardiologia Polska 68(5): 539-543
Zeymer, U.; Tebbe, U.; Weber, M.; Vohringer, H.F.; Jaksch, R.; Bischoff, K.-O.; Toepel, W.; Marsalek, P.; Horn, S.; Neuhaus, K.-L. 2003: Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial Journal of Invasive Cardiology 15(7): 385-389
Tornvall, P.; Johansson, M.; Herzfeld, I.; Nilsson, T. 2001: A controlled trial with prolonged follow up: percutaneous intervention in acute myocardial infarction is equivalent to thrombolytic therapy Lakartidningen 98(32-33): 3397-3399
Xu, J.J.; Tang, X.F.; Song, Y.; Xu, N.; Yao, Y.; Wu, Y.; Zhang, J.; Gao, Z.; Chen, J.; Gao, R.L.; Yang, Y.J.; Yuan, J.Q. 2017: Impact of CYP2C19 genotypes on antiplatelet therapy among Chinese patients with acute myocardial infarction after percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 45(2): 116-120
Farto e Abreu, P. 2003: Percutaneous coronary intervention in acute myocardial infarction Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(6): 857-859
Thompson, C.A. 2009: Transradial approach for percutaneous intervention in acute myocardial infarction Journal of Invasive Cardiology 21(8 Suppl A): 25a-27a
Zhang, Y-chen.; Jia, S-qing.; Wang, L.; Li, H-wei. 2006: The relationship between high sensitivity C-reactive protein level at admission and myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction Zhonghua Xin Xue Guan Bing Za Zhi 34(5): 422-424
Goklaney, A.K.; Murphy, J.D.; Hillegass, W.B. 1998: Abciximab therapy in percutaneous intervention: economic issues in the United States European Heart Journal 19 Suppl D: D52-D58
Jokhi, P.; Talwar, S. 2009: Transradial percutaneous coronary intervention in acute myocardial infarction: in search of a consensus Journal of the Indian Medical Association 107(9): 598 600-1
Zijlstra, F.; de Boer, M.J. 2007: No advantage to referring patients with acute myocardial infarction from a general hospital to an intervention clinic for percutaneous coronary intervention; comparison of mortality rates in 2000 and 2003 in the Meander Medical Centre, Amersfoort Nederlands Tijdschrift Voor Geneeskunde 151(13): 785; Author Reply 785
Tabbers, F.C.A.; Nagtegaal, J.E.; Landman, M.A.J.; van der Westerlaken, M.M.L. 2006: No advantage to referring patients with acute myocardial infarction from a general hospital to an intervention clinic for percutaneous coronary intervention; comparison of mortality rates in 2000 and 2003 in the Meander Medical Centre, Amersfoort Nederlands Tijdschrift Voor Geneeskunde 150(49): 2705-2710
Srimahachota, S.; Boonyaratavej, S.; Udayachalerm, W.; Buddhari, W.; Somabutr, C.; Chayanont, D.; Ngarmukos, P. 2001: Percutaneous coronary intervention in acute myocardial infarction with cardiogenic shock: immediate and late outcomes Journal of the Medical Association of Thailand 84(10): 1449-1454
Yang, K.-P.; Yu, W.-C.; Lu, T.-M. 2013: Acute pericarditis after percutaneous coronary intervention mimicking inferolateral ST-elevation myocardial infarction Journal of Invasive Cardiology 25(2): E27-E29
Włudarczyk-Michalewska, A.; Kaźmierski, M.; Pawłowski, T.; Mróz, I.; Wojakowski, W.; Tendera, M.ł 2010: Plasma adiponectin in patients with acute myocardial infarction treated with percutaneous coronary intervention Kardiologia Polska 68(1): 11-20
Pumprueg, S.; Chotinaiwattarakul, C.; Nopmaneejumruslers, C.; Nimmannit, A.; Wiratchpintu, P.; Charernthai, S. 2007: Primary percutaneous coronary intervention in acute myocardial infarction at Siriraj Hospital: the improvement over time Journal of the Medical Association of Thailand 90(Suppl 2): 19-24
Ma, X.-J.; Zhang, X.-H.; Luo, M.; Li, C.-M.; Shao, J.-H. 2007: Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction Zhonghua Yi Xue Za Zhi 87(2): 114-117
Cai, L.; Wang, F.; Sun, N. 2015: Emergent percutaneous coronary intervention in a patient with acute myocardial infarction at 9 years after heart transplantation Zhonghua Xin Xue Guan Bing Za Zhi 43(9): 827